Amy Raskin, chief investment officer at Chevy Chase Trust, joins CNBC's 'Halftime Report' to explain why she bought Ascendis Pharma and is buying more Cognex, SLB, Fanuc, AIA, CrowdStrike and Impinj.

See Full Page